Home › Precursor T-Cell Lymphoblastic Leukemia-Lymphoma › Tennessee

Pag-aaral pangklinika para sa Precursor T-Cell Lymphoblastic Leukemia-Lymphoma sa Tennessee

3 pag-aaral para sa Precursor T-Cell Lymphoblastic Leukemia-Lymphoma ang naghahanap ng mga kalahok sa mga site sa Tennessee.

Opisyal na teksto ng pag-aaral (English)

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

TriStar Bone Marrow Transplant / Sarah Cannon Transplant & Cellular Therapy, Nashville

Nagre-recruitPhase 2

6 Months · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06514794

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

St. Jude Children's Research Hospital, Memphis

Nagre-recruitPhase 2

Edad 1 hanggang 18 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06390319

CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)

St Jude Children's Research Hospital, Memphis
St. Jude Children's Research Hospital, Memphis

Nagre-recruitPhase 1

Hanggang edad 21 · Lahat ng kasarian · Na-update May 19, 2026 · NCT04318678

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.